Bank of New York Mellon Corp grew its stake in shares of UiPath Inc. (NYSE:PATH - Free Report) by 2.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,437,756 shares of the company's stock after acquiring an additional 66,100 shares during the period. Bank of New York Mellon Corp owned about 0.44% of UiPath worth $30,984,000 at the end of the most recent quarter.
Other hedge funds also recently added to or reduced their stakes in the company. Ontario Teachers Pension Plan Board grew its holdings in UiPath by 136.0% during the 3rd quarter. Ontario Teachers Pension Plan Board now owns 108,725 shares of the company's stock worth $1,392,000 after acquiring an additional 62,650 shares in the last quarter. D.A. Davidson & CO. grew its holdings in UiPath by 60.1% during the 3rd quarter. D.A. Davidson & CO. now owns 557,667 shares of the company's stock worth $7,138,000 after acquiring an additional 209,300 shares in the last quarter. Stifel Financial Corp grew its holdings in UiPath by 30.1% during the 3rd quarter. Stifel Financial Corp now owns 323,818 shares of the company's stock worth $4,145,000 after acquiring an additional 74,959 shares in the last quarter. Senvest Management LLC grew its holdings in UiPath by 16.7% during the 3rd quarter. Senvest Management LLC now owns 10,894,483 shares of the company's stock worth $139,449,000 after acquiring an additional 1,559,500 shares in the last quarter. Finally, Quantbot Technologies LP grew its holdings in UiPath by 667.7% during the 3rd quarter. Quantbot Technologies LP now owns 101,718 shares of the company's stock worth $1,302,000 after acquiring an additional 88,468 shares in the last quarter. 62.50% of the stock is owned by institutional investors and hedge funds.
UiPath Stock Performance
Shares of PATH stock traded down $0.37 during midday trading on Tuesday, reaching $11.75. 15,297,382 shares of the company were exchanged, compared to its average volume of 9,396,978. UiPath Inc. has a 12 month low of $10.37 and a 12 month high of $25.47. The company has a market cap of $6.46 billion, a P/E ratio of -73.41 and a beta of 1.00. The company's 50 day moving average price is $13.48 and its two-hundred day moving average price is $13.19.
Insiders Place Their Bets
In related news, CAO Hitesh Ramani sold 25,000 shares of the business's stock in a transaction that occurred on Friday, January 3rd. The shares were sold at an average price of $13.05, for a total value of $326,250.00. Following the sale, the chief accounting officer now directly owns 269,421 shares in the company, valued at $3,515,944.05. The trade was a 8.49 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Ashim Gupta sold 47,227 shares of the business's stock in a transaction that occurred on Friday, January 3rd. The stock was sold at an average price of $13.06, for a total transaction of $616,784.62. Following the completion of the sale, the chief financial officer now owns 856,538 shares in the company, valued at $11,186,386.28. The trade was a 5.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 22.37% of the stock is owned by insiders.
Analysts Set New Price Targets
PATH has been the subject of several recent analyst reports. Royal Bank of Canada reissued a "sector perform" rating and set a $16.00 price objective on shares of UiPath in a report on Friday, December 6th. Barclays decreased their price target on shares of UiPath from $16.00 to $15.00 and set an "equal weight" rating for the company in a report on Friday, January 10th. JPMorgan Chase & Co. lifted their price target on shares of UiPath from $17.00 to $18.00 and gave the company an "overweight" rating in a report on Friday, December 6th. BMO Capital Markets lifted their price target on shares of UiPath from $15.00 to $16.00 and gave the company a "market perform" rating in a report on Friday, December 6th. Finally, Morgan Stanley lifted their price target on shares of UiPath from $15.00 to $16.00 and gave the company an "equal weight" rating in a report on Friday, December 6th. One investment analyst has rated the stock with a sell rating, sixteen have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, UiPath currently has a consensus rating of "Hold" and an average target price of $17.44.
Read Our Latest Research Report on PATH
About UiPath
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Read More
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
